Bringing medicines to low-income markets

13
1 Bringing Medicines to Low-income Markets Solveig Haupt Solveig Haupt, endeva

description

Presentation by Solveig Haupt, Endeva made at the Euro-Africa Health Investment Conference, March 26 - 27, 2013, London, United Kingdom.

Transcript of Bringing medicines to low-income markets

Page 1: Bringing medicines to low-income markets

1

Bringing Medicines to Low-income MarketsSolveig Haupt

Solveig Haupt, endeva

Page 2: Bringing medicines to low-income markets

2Building knowledge

Data collection Analysis

• Literature research• Identification of >100

case studies with business model character

• Interviews with 30 experts

• Analysis of case studies based on research protocol

• Inductive appoach: Clustering of results to develop framework

• Organisation of data along the framework

Results

What are the key challenges and promsing approaches of business models that aim to serve patients in low income markets with medicines?

Page 3: Bringing medicines to low-income markets

3A market of US$ 158.4 billion

Page 4: Bringing medicines to low-income markets

44 billion underserved people

1.7 billion people without access to essential medicines as defined by WHO

• 50% of population in India and Africa

• 95% of essential medicines are patent-free

„Poverty Penalty“• High medicine prices (tariffs,

mark-ups through middle men)• Expired, counterfeited or out-of-

stock drugs

Health system often substandard• Missing or inefficient infrastructure

and health care providors

Page 5: Bringing medicines to low-income markets

5Challenges

•Lack of Data

•Lack of Legal/Regulatory Environment

•Lack of Physical Infrastructures

•Lack of Health Infrastructure

•Lack of Education and Knowledge

•Lack of Access to Financial Resources

Page 6: Bringing medicines to low-income markets

6The 4As +1 tool

Success Formula

Adapted

Value Proposition +

Value Network

Page 7: Bringing medicines to low-income markets

7Adapted Value Proposition Through „ 4As“

Acceptance

Awareness

Availability

Affordability

Understanding market context and adapting products

Information and Education

Distribution and Dispension

Pricing and Financing instruments

Page 8: Bringing medicines to low-income markets

8With Support Of Innovative Value Networks

• Public sector

• Private sector

• Innternational organizations

• Bilateral donors

• Private foundations

• Micro-finance institutions und Micro-insurer

• NGOs

• Academia

Page 9: Bringing medicines to low-income markets

9Acceptance: DataDyne, Africa

Page 10: Bringing medicines to low-income markets

10Awareness: Sproxil, Worldwide

10

Page 11: Bringing medicines to low-income markets

11Availability: VillageReach & VidaGas, Mozambique

Page 12: Bringing medicines to low-income markets

12Affordability: Sanofi and DNDiS

ourc

e:

Sanofi

Page 13: Bringing medicines to low-income markets

13Thank You